EMEA-002218-PIP01-17
Key facts
Active substance |
Anti-mucosal addressin cell adhesion molecule antibody (SHP647)
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0281/2018
|
PIP number |
EMEA-002218-PIP01-17
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Shire Pharmaceuticals Ireland Limited
Tel. +44 (0)8008 38470 |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|